BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16700522)

  • 1. CD26/DP IV in T cell activation and autoimmunity.
    Preller V; Gerber A; Togni M; Wrenger S; Schraven B; Röcken C; Marguet D; Ansorge S; Brocke S; Reinhold D
    Adv Exp Med Biol; 2006; 575():187-93. PubMed ID: 16700522
    [No Abstract]   [Full Text] [Related]  

  • 2. TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26.
    Preller V; Gerber A; Wrenger S; Togni M; Marguet D; Tadje J; Lendeckel U; Röcken C; Faust J; Neubert K; Schraven B; Martin R; Ansorge S; Brocke S; Reinhold D
    J Immunol; 2007 Apr; 178(7):4632-40. PubMed ID: 17372022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
    Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
    Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
    Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
    J Immunol; 2001 Feb; 166(3):2041-8. PubMed ID: 11160254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
    Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis.
    Sharp AJ; Polak PE; Simonini V; Lin SX; Richardson JC; Bongarzone ER; Feinstein DL
    J Neuroinflammation; 2008 Aug; 5():33. PubMed ID: 18691411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
    Biton A; Bank U; Täger M; Ansorge S; Reinhold D; Lendeckel U; Brocke S
    Adv Exp Med Biol; 2006; 575():177-86. PubMed ID: 16700521
    [No Abstract]   [Full Text] [Related]  

  • 8. ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis.
    Nekrasova T; Shive C; Gao Y; Kawamura K; Guardia R; Landreth G; Forsthuber TG
    J Immunol; 2005 Aug; 175(4):2374-80. PubMed ID: 16081808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH, but not GHRH, plays a role in the development of experimental autoimmune encephalomyelitis.
    Shohreh R; Pardo CA; Guaraldi F; Schally AV; Salvatori R
    Endocrinology; 2011 Oct; 152(10):3803-10. PubMed ID: 21846799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
    Biton A; Ansorge S; Bank U; Täger M; Reinhold D; Brocke S
    Immunobiology; 2011 Dec; 216(12):1295-301. PubMed ID: 21802166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity.
    Reinhold D; Kähne T; Steinbrecher A; Wrenger S; Neubert K; Ansorge S; Brocke S
    Biol Chem; 2002; 383(7-8):1133-8. PubMed ID: 12437097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein.
    Mendel I; Natarajan K; Ben-Nun A; Shevach EM
    J Neuroimmunol; 2004 Apr; 149(1-2):10-21. PubMed ID: 15020060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.
    Bullard DC; Hu X; Adams JE; Schoeb TR; Barnum SR
    Am J Pathol; 2007 Jun; 170(6):2001-8. PubMed ID: 17525267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic selection can compensate for mutations affecting T cell activation and generate a normal T cell repertoire in mutant mice.
    Kissler S; Lu L; Cantor H
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):210-4. PubMed ID: 14694195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 ligand is a new therapeutic target for central nervous system autoimmunity.
    Shinoda K; Sun X; Oyamada A; Yamada H; Muta H; Podack ER; Kira J; Yoshikai Y
    J Autoimmun; 2015 Feb; 57():14-23. PubMed ID: 25533628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
    Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
    J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis.
    Sekiguchi Y; Ichikawa M; Takamoto M; Ota H; Koh CS; Muramatsu M; Honjo T; Agematsu K
    Immunol Lett; 2009 Feb; 122(2):145-9. PubMed ID: 18824198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.